Daily MDOI Identifier Registry

Using Machine Learning to Match Clients and Therapy Providers: Evaluating Clinical Quality and Cost of Care

The Cost-Effectiveness of an Artificial Intelligence-Based Population-Wide Screening Program for Primary Open-Angle Glaucoma in The Netherlands

Synergizing Needs Assessments and Patient Preference Studies for Enhanced Patient-Centered Decision Making in Healthcare

Psychometric Properties of the Modified EQ Health and Wellbeing and its Shorter Version in a General Chinese Population: A Comparative Analysis With EQ-5D-5L, SF-6Dv2, ICEpop CAPability measure for Adults, Short Version of Warwick-Edinburgh Mental Wellbeing Scale, and World Health Organization Well-Being Index 5-Item

Understanding the Transition Between Age-Specific Measures of Health-Related Quality of Life: Evidence on the Relationship Between and Comparative Performance of the EQ-5D-Y-5L and EQ-5D-5L

The Psychometric Performance of the EQ Health and Wellbeing in Caregivers of Persons Living With Dementia

Mapping EQ-5D-5L Utilities in Dementia: Integrating Self and Proxy Reports

Exemption System for Economic Evaluation Data Submission for Pharmaceuticals in South Korea: Achievements and Challenges

Costs and Outcomes After Primary and Revision Hip Replacements by Implant Bearing Materials: Analysis of 550 760 linked Patient Records from English Routinely Collected Databases

The Burden of Mitochondrial Disease: Healthcare and Societal Costs

Statistical Methods for Analyzing EQ-5D in Randomized Clinical Trials: A Systematic Literature Review

A Scoping Review of Interventions to Reduce the Environmental Footprint of Healthcare

The Role of Mental Health in Healthcare Choices: A Discrete Choice Experiment Examining Preferences for Primary Care

Mapping the Kidney Disease Quality-of-Life Questionnaire Onto the EQ-5D-5L Utility Index in Patients Undergoing Hemodialysis

Psychometric Performance of a New Condition-Specific Preference-Weighted Measure, Vision Impairment in Low Luminance-Utility Index, and EQ-5D-5L in Patients With Age-Related Macular Degeneration: A MACUSTAR Study Report

Psychometric Evaluation of the Proxy-Reported Pediatric Quality of Life Inventory Generic Core Scales Across the Childhood Lifespan in Australian Children and Adolescents With Specified Health Conditions

Identifying the Influential Dynamic Inputs in Cost-Effectiveness Analyses

Stakeholder Views on the Use and Challenges of Using Early Economic Evaluations in Health Innovation Development in The Netherlands

Economic Evaluation Results Are Substantially Affected by Parameter Input Correlation

Potential Impact of EQ-5D-5L Mapping Function Recently Recommended by the National Institute for Health and Care Excellence on Utility Values and Decision Making

Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States

First-Line Alectinib, Brigatinib, and Lorlatinib for Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis

Cost-Effectiveness of Enfortumab Vedotin and Pembrolizumab for First-Line Metastatic Urothelial Cancer in the United States

Cost-Utility Analysis of Durvalumab and Tremelimumab Versus Best Supportive Care in Refractory Metastatic Colorectal Cancer

The Argument-Based Approach to Validity Applied to Clinical Outcome Assessments: Some History and Notable Features

R Packages for Matching-Adjusted Indirect Comparison: Differences in Usability and Identical Results From Reuse of Prior Code

Quantifying the Impact of Intervention on Health Outcomes: A Tool for Assessing Incremental Changes to Life Expectancy

Research Method, Conduct, and Reporting Considerations for Improving the Quality of Non-Hypothesis-Evaluating Treatment Effectiveness Analyses Using Real-World Data: An ISPOR Working Group Report

Screening for Type 2 Diabetes Mellitus: A Systematic Review of Recent Economic Evaluations

Economic Evaluation of Internet-Based Psychological Interventions: A Scoping Review of Methodological Choices

Economic Evaluation of Internet-Based Psychological Interventions: A Scoping Review of Methodological Choices

Can Adolescents Value the EQ-5D-Y-5L and EQ-5D-5L, and How Do the Values Compare? A Feasibility Study

The New Dutch Guideline for Economic Evaluations in Healthcare: Taking the Societal Perspective to the Next Level

Quality-Adjusted Life Expectancy by Socioeconomic Disadvantage and Remoteness Area: Population Norms for Australia

Performance of the EQ-5D-5L With Skin Irritation and Self-Confidence Bolt-On Items in Patients With Urticaria

cost-effectiveness analysis, dynamic pricing, life-cycle drug pricing, net price

Use of Real-World Evidence in Health Technology Reassessments Across 6 Health Technology Assessment Agencies

Drop the “M”: Minimally Important Difference and Change Are Not Independent Properties of an Instrument and Cannot Be Determined as a Single Value Using Statistical Methods

Quantifying Low-Value Care in Germany: An Observational Study Using Statutory Health Insurance Data From 2018 to 2021

A Person-Centered eHealth Intervention for Patients With Common Mental Disorders: Cost-Effectiveness Analysis Within a Randomized Controlled Trial

The Health Inequality Impact of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer in the United States: A Distributional Cost-Effectiveness Analysis

Costs and Health Outcomes in Economic Evaluations of Person-Centered Care: A Systematic Review

A Managed Access Protocol for Liraglutide for Weight Management: A Retrospective, Observational Study in Ireland

When Do Value-Based Contracts Add Value? Insights From Probabilistic Simulations

The Value of Positron Emission Tomography for Confirmation of Alzheimer’s Disease in the Era of Amyloid-Targeting Therapies

Understanding the Economic Value of Interventions Addressing Perinatal Mental Health Problems: A Literature Review and Methodological Considerations

Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis: An ISPOR Special Interest Group Report

P3 Long Term Healthcare Costs and Utilization Among Patients with Non Obstructive Hypertrophic Cardiomyopathy

P2 Healthcare Resource Utilization (HCRU) and Cost among Patients with Metastatic Melanoma Receiving Nivolumab + Relatlimab (NIVO+RELA) or Nivolumab + Ipilimumab (NIVO+IPI) in the Optum Database

P1 Economic Burden of Recurrence among Patients with High-Risk Non-Muscle-Invasive Bladder Cancer who Received Bacillus Calmette-Guérin in the United States: A SEER-Medicare Study